<code id='3DB6CCDFFE'></code><style id='3DB6CCDFFE'></style>
    • <acronym id='3DB6CCDFFE'></acronym>
      <center id='3DB6CCDFFE'><center id='3DB6CCDFFE'><tfoot id='3DB6CCDFFE'></tfoot></center><abbr id='3DB6CCDFFE'><dir id='3DB6CCDFFE'><tfoot id='3DB6CCDFFE'></tfoot><noframes id='3DB6CCDFFE'>

    • <optgroup id='3DB6CCDFFE'><strike id='3DB6CCDFFE'><sup id='3DB6CCDFFE'></sup></strike><code id='3DB6CCDFFE'></code></optgroup>
        1. <b id='3DB6CCDFFE'><label id='3DB6CCDFFE'><select id='3DB6CCDFFE'><dt id='3DB6CCDFFE'><span id='3DB6CCDFFE'></span></dt></select></label></b><u id='3DB6CCDFFE'></u>
          <i id='3DB6CCDFFE'><strike id='3DB6CCDFFE'><tt id='3DB6CCDFFE'><pre id='3DB6CCDFFE'></pre></tt></strike></i>

          leisure time

          leisure time

          author:Wikipedia    Page View:69
          Sammy Kimball for STAT

          Is Wegovy really a brain drug? Which Alzheimer’s disease treatment works best? And what’s the point of Threads?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Megan Molteni joins us to explain the evolving science suggesting products like Wegovy are less weight loss drugs than treatments for human desire. We also explain why this summer is shaping up to be a pivotal moment for the treatment of Alzheimer’s and discuss our befuddlement with the latest social media platform.

          advertisement

          For more on what we cover, here’s the story on GLP-1 drugs and the brain; here’s the latest on Leqembi; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          explore

          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more
          Roche’s Alnylam deal shows drug firms interested in heart drugs
          Roche’s Alnylam deal shows drug firms interested in heart drugs

          AdobeRoche’sannouncementMondaythatitwouldpay$310millionforrightstoahypertensiontreatment,zilebesiran

          read more
          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more

          Rise in cancer among younger people worries and puzzles doctors

          Atumorinvasionintoaveininacaseofcolorectalcancer.WikimediaCommonsWhenboththenurseandthe doctorbroked